Table 2.
Q-SIT in controls, COVID+ patients without smell loss, and COVID+ patients with smell loss.
| QSIT score | Controls N- % (95% CI) |
COVID+ w/o SL N- % (95% CI) |
COVID+ w/ SL N- % (95% CI) |
Total N- % (95% CI) |
|---|---|---|---|---|
| 0 correct | 0–0.0% (0.0%–9.8%) |
4–11.8% (3.3%–27.5%) |
12–52.2% (30.6%–73.2%) |
16–17.2% (10.2%–26.4%) |
| 1 correct | 4–11.1% (3.1%–26.1%) |
7–20.6% (8.7%–37.9%) |
9–39.1% (19.7%–61.5%) |
20–21.5% (13.7%–31.2%) |
| 2 correct | 7–19.4% (8.2%–36.0%) |
10–29.4% (15.1%–47.5%) |
2–8.7% (1.1%–28.0%) |
19–20.4% 12.8%–30.1% |
| 3 correct | 25–69.4% (51.9%–83.7%) |
13–38.2% (22.2%–56.4%) |
0–0.0% (0.0%–14.8%) |
38–40.9% (30.8%–51.5%) |
N: number of patients; % percentage; (CI) confidence interval; COVID+ w/o SL: COVID+ patients with reported smell loss; COVID+ w/ SL: COVID+ patients without smell loss.